Fluorobenzene

Fluorobenzene

SCHEMBL7167290

Fc1ccccc1.O=S(=O)(Cl)c1ccccc1

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.76
HSD17B10 Q99714 1/20 0.76
TDP1 Q9NUW8 1/20 0.76
APOBEC3G Q9HC16 1/20 0.48
PKM P14618 1/20 0.47
HTR6 P50406 1/20 0.46
HSD11B1 P28845 2/20 0.43
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA7 P43166 2/20 0.42
CA13 Q8N1Q1 2/20 0.42
TSHR P16473 2/20 0.42
CA3 P07451 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42
PLA2G7 Q13093 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17223 0.87 TDP1 (1.00) ALDH1A1HSD17B10TDP1APOBEC3GHTR6
SCHEMBL18636497 0.87 TDP1 (1.00) ALDH1A1HSD17B10TDP1APOBEC3GHTR6
Benzene SCHEMBL4292987 0.87 TDP1 (1.00) ALDH1A1HSD17B10TDP1APOBEC3GHTR6
SCHEMBL10704793 0.87 TDP1 (1.00) ALDH1A1HSD17B10TDP1APOBEC3GHTR6
SCHEMBL30036615 0.87 TDP1 (1.00) ALDH1A1HSD17B10TDP1APOBEC3GHTR6
SCHEMBL10999079 0.85 TDP1 (0.84) ALDH1A1HSD17B10TDP1APOBEC3GHTR6
SCHEMBL3810753 0.85 TDP1 (0.94) ALDH1A1HSD17B10TDP1APOBEC3GHTR6
Bromide SCHEMBL28859264 0.85 TDP1 (0.94) ALDH1A1HSD17B10TDP1APOBEC3GHTR6
Fluorobenzene SCHEMBL379263 0.85 HSD17B10 (0.50) ALDH1A1HSD17B10TDP1APOBEC3GPKM
Methane SCHEMBL29110024 0.85 TDP1 (0.94) ALDH1A1HSD17B10TDP1APOBEC3GHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506761-B1 Compound of the invention are active as inhibitors of Thrombin and are useful in treating disease states in mammals which are characterized by abnormal thrombosis and have the following structure: CORVAS INTERNATIONAL, INC. 2003-01-14 US disclosed
US-6506760-B1 Compounds of the invention are active as inhibitors of Thrombin and are useful in treating disease states in mammals which are characterized by abnormal thrombosis and have the following structure: CORVAS INTERNATIONAL, INC. 2003-01-14 US disclosed
WO-2001079193-A2 SUBSTITUTED HYDRAZINYL HETEROAROMATIC INHIBITORS OF THROMBIN CORVAS INTERNATIONAL, INC. (US) 2001-10-25 WO disclosed